Best in Biotech 16 Jan 2025Ten first-in-class drugs on track for FDA approval in 2025 As the year unfolds the biotech industry will look closely at these ten first-in-class drugs on track to reach FDA approval in 2025. January 16, 2025 - 13 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 13 Jan 20252025 predictions: Which trends are set to shape the biotech industry this year? From AI to gene therapy, we reached out to industry experts to get their thoughts on the trends that will shape the biotech industry in 2025. January 13, 2025 - 18 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 10 Jan 2025The in vivo revolution: How Interius, Umoja, and Vyriad are transforming CAR-T cell therapy A U.S. trial of an in vivo CAR gene therapy has expanded to Europe, marking the first-ever trial of its kind in the region. January 10, 2025 - 5 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 25 Dec 2024When biotech makes Christmas miracles a reality Explore how biotech breakthroughs in 2024 have changed lives, bringing real Christmas miracles to patients and offering hope for the future. December 25, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 27 Nov 2024Charcot–Marie–Tooth disease: what’s going on in the clinical field? In this article, we take a look at the various treatments in development to address the unmet needs of people with Charcot–Marie–Tooth disease. November 27, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 21 Nov 2024Huntington’s disease: a therapeutic field on a bumpy ride For years, biotechs have been trying to develop medicines to cure the disease but much to no avail. Now, as clinical studies advance, there is hope. November 21, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 21 Nov 2024Eight areas where gene therapy shines Delve into the numerous applications of gene therapy, from cancer to hematological disorders and respiratory diseases. November 21, 2024 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 11 Nov 2024Gene editing sector investment struggles: What’s driving the slowdown? Find out what is driving the slowdown in gene therapy investment, as the sector continues to struggle with widespread layoffs. November 11, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 7 Nov 2024Cystic fibrosis: Five biotechs breathing life into the therapeutic space In this article, we take a look at five biotechs developing potentially transformative medicines to treat this genetic disease. November 7, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Sponsored by KBI Biopharma 5 Nov 2024Unlocking AAV gene therapy potential: The role of successful characterization Explore the role and challenges of AAV characterization, the significance of capsid filling, and the best methods to enhance gene therapy. November 5, 2024 - 8 minutesmins - By Ute Boronowsky Share WhatsApp Twitter Linkedin Email
News and Trends 4 Nov 2024Top biotech deals of October 2024 Discover the major biotech partnerships, collaborations and mergers and acquisitions that made headlines in October 2024. November 4, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Podcast 18 Oct 2024The future of gene therapy This week, we have a conversation with Michael Parini, CEO of Spur Therapeutics, about the future of gene therapy. October 18, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More